ABO Blood Group and Risk of Venous Thrombosis in Heterozygous Carriers of Factor V Leiden

• References

• 1 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
• 2 Tosetto A, Rodeghiero F, Martinelli I, De Stefano V, Missiaglia E, Chiusolo P, Manucci PM. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation. Brit J Haematol 1998; 103: 871-6.
• 3 Jick H, Westerholm B, Vessey MP, Lewis GP, Slone D, Inman WHW, Shapiro S, Worcester J. Venous thromboembolic disease and ABO blood group type. A cooperative study. Lancet 1969; 01: 539-42.
• 4 Talbot S, Ryrie D, Wakley EJ, Langman MJS. ABO blood-group and venous thromboembolic disease. Lancet 1970; 01: 1257-9.
• 5 Koster T, Blann AD, Briët E, Vandenbroocke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345.
• 6 Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 689-90.
• 7 Gonzales AJOrdonez, Medina Rodriguez JM, Martin L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coag Fibrinolysis 1999; 10: 303-307.
• 8 Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
• 9 McLellan DS, Knight SR, Aronstam A. The relationship between coagulation factor VIII and ABO blood group status. Med Lab Sci 1988; 45: 131-4.